Europe – Consultation on the pilot project ‘Market Launch Intentions of Centrally Authorised Products’

In the EU, a medicinal product can be placed on the market after it has received a marketing authorisation. A centralized marketing authorisation granted by the European Commission is valid throughout the EU, allowing the marketing of the medicinal product in all Member States. However, in practice, there are still important differences as regards when (if at all) a newly (centrally) authorised medicine is made available in each EU Member State…